Cargando…

Use of Proton Pump Inhibitors and the Risk of Hospitalization for Infectious Gastroenteritis

INTRODUCTION: To quantify the association between PPI use, type and dose and infectious gastroenteritis hospitalization in a population-based cohort of middle-aged and older adults. METHODS: Prospective study of 38,019 concession card holders followed up over 6 years in the Sax Institute’s 45 and Up...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yingxi, Liu, Bette, Glass, Kathryn, Du, Wei, Banks, Emily, Kirk, Martyn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173244/ https://www.ncbi.nlm.nih.gov/pubmed/27997598 http://dx.doi.org/10.1371/journal.pone.0168618

Ejemplares similares

High incidence of hospitalisation due to infectious gastroenteritis in older people associated with poor self-rated health
por: Chen, Yingxi, et al.
Publicado: (2015)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Prescribing Antimicrobial Drugs for Acute Gastroenteritis, Primary Care, Australia, 2013–2018
por: He, Wen-Qiang, et al.
Publicado: (2021)

Socio-demographic and health service factors associated with antibiotic dispensing in older Australian adults
por: Chen, Yingxi, et al.
Publicado: (2019)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Proton pump inhibitors and the risk of hospital-acquired acute kidney injury in children
por: Li, Yanqin, et al.
Publicado: (2020)

Evaluation of proton pump inhibitor administration in hospitalized dogs in a tertiary referral hospital
por: Duxbury, Samantha, et al.
Publicado: (2022)

Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias
por: El-Charabaty, Elie, et al.
Publicado: (2013)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

Molecular diagnostic practices for infectious gastroenteritis
por: Shen, Nan, et al.
Publicado: (2020)

Association Between Acute Gastroenteritis and Continuous Use of Proton Pump Inhibitors During Winter Periods of Highest Circulation of Enteric Viruses
por: Vilcu, Ana-Maria, et al.
Publicado: (2019)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors versus proton pump inhibitors plus prokinetics
por: Revaiah, Pruthvi C, et al.
Publicado: (2018)

Proton Pump Inhibitors and the Risk of Adverse Cardiac Events
por: Juurlink, David N., et al.
Publicado: (2013)

Proton pump inhibitors: Review of reported risks and controversies
por: Brisebois, Simon, et al.
Publicado: (2018)

Proton pump inhibitors increase risk of COVID-19
Publicado: (2020)

Use of proton pump inhibitors for the risk of gastric cancer
por: Gao, Huiqin, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients
por: de Francisco, Angel L.M., et al.
Publicado: (2017)

Proton pump inhibitors as a risk factor for norovirus infection
por: PRAG, C., et al.
Publicado: (2017)

Proton pump inhibitors and the risk of gallbladder cancer: a hospital-based case–control study
por: Xiong, Jianping, et al.
Publicado: (2020)

Proton Pump Inhibitors: Current Use and the Risk of Coronavirus Infectious Disease 2019 Development and its Related Mortality. Meta-analysis
por: Toubasi, Ahmad Amjed, et al.
Publicado: (2021)

Risk Factors for Acute Respiratory Infection in the Australian Community
por: Chen, Yingxi, et al.
Publicado: (2014)

Acute infectious nonbacterial gastroenteritis (AING)
por: Friedman, Allan D.
Publicado: (1983)

The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum
por: Hussain, Zilla H, et al.
Publicado: (2015)

The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum
por: Hussain, Zilla H, et al.
Publicado: (2015)

Estimating Foodborne Gastroenteritis, Australia
por: Hall, Gillian, et al.
Publicado: (2005)

Delirium in the geriatric unit: proton-pump inhibitors and other risk factors
por: Otremba, Iwona, et al.
Publicado: (2016)

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
por: Shah, Nigam H., et al.
Publicado: (2015)

Increased Proton Pump Inhibitors−Induced Mortality Risk in Hemodialysis Patients
por: Sertorio, Jonas T., et al.
Publicado: (2018)

An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19
por: Homolak, Jan, et al.
Publicado: (2021)

Proton pump inhibitors and the risk of Alzheimer’s disease and non-Alzheimer’s dementias
por: Torres-Bondia, Francisco, et al.
Publicado: (2020)

Proton Pump Inhibitors Use and Risk of Preeclampsia: A Meta-Analysis
por: Hussain, Salman, et al.
Publicado: (2022)

Proton Pump Inhibitor Use and Risk of Serious Infections in Young Children
por: Lassalle, Marion, et al.
Publicado: (2023)

Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients
por: Barletta, Jeffrey F, et al.
Publicado: (2014)

Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_obbb5tm30f03268hp4nn8b5383